FindTrial
Sign In

Safety and efficacy of microconvex ultrasound-guided radiofrequency treatment of the sphenopalatine ganglion for refractory head and facial pain: a retrospective clinical case series

Safety and efficacy of microconvex ultrasound-guided radiofrequency treatment of the sphenopalatine ganglion for refractory head and facial pain: a retrospective clinical case series

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056569
Enrollment
Unknown
Registered
2022-02-08
Start date
2022-02-06
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cranio-facial pain

Interventions

Case series:None

Sponsors

Guangdong Second Provincial General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
32 Years to 81 Years

Inclusion criteria

Inclusion criteria: From October 2018 to October 2021, patients with refractory head and facial pain underwent ultrasound-guided radiofrequency surgery for sphenopalatine ganglion in the Department of Pain, The Second People's Hospital of Guangdong Province.

Exclusion criteria

Exclusion criteria: 1. Cancer patients; 2. Severe heart, liver or other systemic diseases; 3. Severe anxiety, depression or cognitive impairment; 4. Pregnancy or lactation; 5. Severe infection at the puncture site.

Design outcomes

Primary

MeasureTime frame
Visual analogue scoring;—

Countries

China

Contacts

Public ContactBo Cunju

Guangdong Second Provincial General Hospital

cunjubo@126.com+86 13751811736

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026